Literature DB >> 27463051

Prevalence of occult hepatitis C virus infection in the Iranian patients with human immunodeficiency virus infection.

Farah Bokharaei-Salim1,2, Hossein Keyvani1, Maryam Esghaei1, Shohreh Zare-Karizi3, Sahar-Sadat Dermenaki-Farahani4, Khashayar Hesami-Zadeh1, Shahin Fakhim5.   

Abstract

Occult hepatitis C virus (HCV) infection is a new form of chronic HCV infection described by the presence of the genomic HCV-RNA in liver biopsy and/or peripheral blood mononuclear cell (PBMC) samples, and undetectable levels or absence of HCV-RNA and in the absence or presence of anti HCV antibodies in the plasma specimens. The aim of the present study was to evaluate the occurrence of occult HCV infection (OCI) among Iranian subjects infected with human immunodeficiency virus (HIV) using RT-nested PCR. From March 2014 until April 2015, 109 Iranian patients with established HIV infection were enrolled in this cross-sectional study. After extraction of viral RNA from the plasma and PBMC samples, HCV-RNA status was examined by RT-nested PCR using primers from the 5'-NTR. HCV genotyping was conducted using RFLP analysis. For the confirmation of HCV genotyping by RFLP method, the PCR products were sequenced. Of the 109 patients, 50 were positive for antibodies against HCV. The HCV-RNA was detected in PBMC specimens in 6 (10.2%) out of the total 59 patients negative for anti-HCV Abs and undetectable plasma HCV-RNA and also from 4 (8.0%) out of the total 50 patients positive for anti-HCV Abs and undetectable plasma HCV-RNA. HCV genotyping analysis showed that 6 (60.0%) patients were infected with HCV subtype 3a, 3 (30.0%) were infected with HCV subtype 1a and 1 (10.0%) patient was infected with HCV subtype 1b. This study revealed the incidence of OCI (9.2%) in HIV-infected Iranian patients. Hence, designing prospective studies focusing on the detection of OCI in these patients would provide more information. J. Med. Virol. 88:1960-1966, 2016.
© 2016 Wiley Periodicals, Inc. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  hepatitis C virus; human immunodeficiency virus; occult HCV infection; peripheral blood mononuclear cells

Mesh:

Substances:

Year:  2016        PMID: 27463051     DOI: 10.1002/jmv.24474

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  8 in total

1.  Hepatitis C Virus Coinfection in People With Human Immunodeficiency Virus in Iran: A Systematic Review and Meta-Analysis.

Authors:  Seyedeh-Kiana Razavi-Amoli; Abbas Alipour
Journal:  Open Forum Infect Dis       Date:  2022-09-21       Impact factor: 4.423

2.  The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.

Authors:  Fatemeh Afsharzadeh; Farah Bokharaei-Salim; Maryam Esghaei; Seyed Hamidreza Monavari; Shahin Merat; Hossein Poustchi; Arghavan Haj-Sheykholeslami; Hossein Keyvani
Journal:  Hepat Mon       Date:  2016-12-11       Impact factor: 0.660

3.  Molecular Epidemiology of Kaposi's Sarcoma-Associated Herpes Virus, and Risk Factors in HIV-infected Patients in Tehran, 2014.

Authors:  Khashayar Hesamizadeh; Hossein Keyvani; Farah Bokharaei-Salim; Seyed Hamidreza Monavari; Maryam Esghaei; Fatemeh Jahanbakhsh Sefidi
Journal:  Iran Red Crescent Med J       Date:  2016-06-19       Impact factor: 0.611

4.  Prevalence of hepatitis C virus among HIV-infected patients.

Authors:  Elham Zayedi; Manoochehr Makvandi; Ali Teimoori; Ali Reza Samarbaf-Zadeh; Shokouh Ghafari; Seyed Saeed Seyedian; Azarakhsh Azaran
Journal:  Iran J Microbiol       Date:  2020-04

5.  Expression profiling of inflammation-related genes including IFI-16, NOTCH2, CXCL8, THBS1 in COVID-19 patients.

Authors:  Shahrzad Hamldar; Seyed Jalal Kiani; Majid Khoshmirsafa; Javid Sadri Nahand; Hamed Mirzaei; AliReza Khatami; Roya Kahyesh-Esfandiary; Khadijeh Khanaliha; Ahmad Tavakoli; Kimiya Babakhaniyan; Farah Bokharaei-Salim
Journal:  Biologicals       Date:  2022-09-13       Impact factor: 1.760

6.  HIV-1 reverse transcriptase and protease mutations for drug-resistance detection among treatment-experienced and naïve HIV-infected individuals.

Authors:  Farah Bokharaei-Salim; Maryam Esghaei; Khadijeh Khanaliha; Saeed Kalantari; Arezoo Marjani; Atousa Fakhim; Hossein Keyvani
Journal:  PLoS One       Date:  2020-03-02       Impact factor: 3.240

7.  Prevalence of hepatitis C virus genotypes in HIV positive patients referring to the consultation center for behavioral diseases, Sanandaj, Iran.

Authors:  Samira Amini; Mazaher Khodabandehloo
Journal:  Iran J Microbiol       Date:  2020-12

Review 8.  Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus.

Authors:  Anna Wróblewska; Krzysztof Piotr Bielawski; Katarzyna Sikorska
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.